Efficacy and safety of repetitive transcranial magnetic stimulation in the treatment of male smokers with tobacco use disorder: a randomized controlled trial

Abstract Background Tobacco use disorder (TUD) is a long-term condition marked by compulsive smoking, intense cravings, and withdrawal effects. Repetitive transcranial magnetic stimulation (r-TMS), which targets the left dorsolateral prefrontal cortex (DLPFC), has been identified as a promising therapeutic approach. However, research on the use of r-TMS for treating TUD in Egypt remains scarce. This study aimed to assess the effectiveness of active r-TMS in reducing smoking behavior, withdrawal symptoms, cravings, and nicotine dependence, in comparison to sham treatment, while also examining its tolerability as a treatment option for TUD. Results Forty male smokers (aged 18–60 years) who smoked a minimum of 10 cigarettes per day for a minimum of 12 months were randomized into two groups: the active r-TMS group ( n = 20) and the sham group ( n = 20). Active r-TMS treatment, delivered over 15 sessions (5 sessions weekly for 3 consecutive weeks), significantly reduced the number of cigarettes smoked daily ( p = 0.001), nicotine dependence ( p = 0.023), withdrawal symptoms (both self-reported and observer-rated) ( p = 0.001), and craving ( p = 0.007) compared to the sham treatment. Urinary cotinine levels, a biomarker of nicotine intake, were also significantly lower in the active r-TMS group during the follow-up period ( p = 0.011). The treatment was generally well-tolerated, with only minor side effects, such as headaches (22.5%). Conclusions Active r-TMS targeting the left DLPFC effectively reduced nicotine dependence, withdrawal symptoms, and craving, demonstrating its potential as a promising treatment for TUD. These findings align with previous studies supporting the efficacy of r-TMS in addiction treatment. Further research is needed to optimize treatment protocols, explore combined therapies, and assess long-term outcomes to improve smoking cessation in diverse populations.

Authors

Institutions

Publication Details

Journal
Middle East Current Psychiatry
Published
2025-02-03
DOI
https://doi.org/10.1186/s43045-025-00503-3
Primary Topic
Transcranial Magnetic Stimulation Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and safety of repetitive transcranial magnetic stimulation in the treatment of male smokers with tobacco use disorder: a randomized controlled trial

Gehan F. Attia, Ahmed Badawy, Wesam Abd El Salam Ghareeb, S. Mousa
Middle East Current Psychiatry
Transcranial Magnetic Stimulation Studies
article

Efficacy and safety of repetitive transcranial magnetic stimulation in the treatment of male smokers with tobacco use disorder: a randomized controlled trial

Gehan F. Attia, Ahmed Badawy, Wesam Abd El Salam Ghareeb, S. Mousa
article en

Abstract

Abstract Background Tobacco use disorder (TUD) is a long-term condition marked by compulsive smoking, intense cravings, and withdrawal effects. Repetitive transcranial magnetic stimulation (r-TMS), which targets the left dorsolateral prefrontal cortex (DLPFC), has been identified as a promising therapeutic approach. However, research on the use of r-TMS for treating TUD in Egypt remains scarce. This study aimed to assess the effectiveness of active r-TMS in reducing smoking behavior, withdrawal symptoms, cravings, and nicotine dependence, in comparison to sham treatment, while also examining its tolerability as a treatment option for TUD. Results Forty male smokers (aged 18–60 years) who smoked a minimum of 10 cigarettes per day for a minimum of 12 months were randomized into two groups: the active r-TMS group ( n = 20) and the sham group ( n = 20). Active r-TMS treatment, delivered over 15 sessions (5 sessions weekly for 3 consecutive weeks), significantly reduced the number of cigarettes smoked daily ( p = 0.001), nicotine dependence ( p = 0.023), withdrawal symptoms (both self-reported and observer-rated) ( p = 0.001), and craving ( p = 0.007) compared to the sham treatment. Urinary cotinine levels, a biomarker of nicotine intake, were also significantly lower in the active r-TMS group during the follow-up period ( p = 0.011). The treatment was generally well-tolerated, with only minor side effects, such as headaches (22.5%). Conclusions Active r-TMS targeting the left DLPFC effectively reduced nicotine dependence, withdrawal symptoms, and craving, demonstrating its potential as a promising treatment for TUD. These findings align with previous studies supporting the efficacy of r-TMS in addiction treatment. Further research is needed to optimize treatment protocols, explore combined therapies, and assess long-term outcomes to improve smoking cessation in diverse populations.

Middle East Current PsychiatryVol. 32(1)
Tanta University (EG)
Tanta University
Openalex Percentile: Top 98%
Transcranial Magnetic Stimulation Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.